Phase I/II trial of perioperative avelumab in combination with chemoradiation (CRT) in the treatment of stage II/III resectable esophageal and gastroesophageal junction (E/GEJ) cancer.

被引：0
|
作者：
Uboha, Nataliya Volodymyrivna
Eickhoff, Jens C.
Maloney, James D.
McCarthy, Daniel
DeCamp, Malcolm
Deming, Dustin A.
LoConte, Noelle K.
Matkowskyj, Kristina A.
Patel, Monica Arun
Hurst, Newton
Kratz, Jeremy D.
Lubner, Sam Joseph
Bassetti, Michael Frederick
机构：
[1] UW Carbone Canc Ctr, Madison, WI USA
[2] Univ Wisconsin, Dept Biostat, Madison, WI USA
[3] Univ Wisconsin, Div Cardiothorac Surg, Dept Surg, Madison, WI USA
[4] Univ Wisconsin, Madison, WI USA
[5] ECOG ACRIN, Madison, WI USA
[6] Univ Michigan, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4034
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Aggressive multimodality therapy for stage III esophageal cancer: A phase I/II study
    Alexander, EP
    Lipman, T
    Harmon, J
    Wadleigh, R
    ANNALS OF THORACIC SURGERY, 2000, 69 (02): : 363 - 368
  • [42] Phase I/II trial of combination topotecan and vinorelbine in patients with refractory gynecologic cancer.
    Berchuck, A
    Secord, AA
    Havrilesky, LJ
    Wenham, R
    Soper, JT
    Clarke-Pearson, DL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 487S - 487S
  • [43] Phase II study of neoadjuvant chemotherapy with modified FOLFOXIRI in borderline resectable or unresectable stage III pancreatic cancer.
    Vasile, Enrico
    De Lio, Nelide
    Cappelli, Carla
    Pollina, Luca
    Funel, Niccola
    Sainato, Aldo
    Ginocchi, Laura
    Lucchesi, Maurizio
    Caparello, Chiara
    Caponi, Sara
    Perrone, Vittorio
    Pasqualetti, Francesco
    Caniglia, Fabio
    Signori, Stefano
    Mazzeo, Salvatore
    Greco, Carlo
    Falcone, Alfredo
    Campani, Daniela
    Mosca, Franco
    Boggi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] IDEAL CRT: ISOTOXIC DOSE ESCALATION AND ACCELERATION IN LUNG CANCER CHEMORADIOTHERAPY - A PHASE I/II TRIAL OF CONCURRENT CHEMORADIATION WITH DOSE-ESCALATED RADIOTHERAPY IN PATIENTS WITH STAGE II OR STAGE III NON-SMALL CELL LUNG CANCER
    Landau, David B.
    Khan, Iftekhar
    Ngai, Yenting
    Hughes, Laura L.
    Miles, Elizabeth
    Wilkinson, Dean
    Parsons, Emma
    Mayles, Philip
    Mayles, Helen
    Bates, Andrew T.
    Mohammed, Nazia
    Hicks, Jonathan
    Harden, Susan
    Illsley, Marianne
    Garcia, Angel
    Malik, Zafar
    Hughes, Simon
    Spicer, James
    Baker, Angela
    Wells, Paula
    Laurence, Virginia
    Fenwick, John
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S190 - S190
  • [45] A phase II study: Combination of sorafenib with docetaxel and cisplatin in the treatment of metastatic or advanced unresectable gastric and gastroesophageal junction (GEJ) adenocarcinoma (ECOG 5203)
    Sun, W.
    Powell, M. E.
    O'Dwyer, P.
    Ansari, R. H.
    Benson, A. B., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
    Thorsten O. Götze
    Pompiliu Piso
    Sylvie Lorenzen
    Ulli S. Bankstahl
    Claudia Pauligk
    Moustafa Elshafei
    Giuseppe Amato
    Daniel Reim
    Wolf O. Bechstein
    Alfred Königsrainer
    Stefan P. Mönig
    Beate Rau
    Matthias Schwarzbach
    Salah-Eddin Al-Batran
    BMC Cancer, 21
  • [47] Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"-(FLOT9) trial of the AIO/CAOGI /ACO
    Goetze, Thorsten O.
    Piso, Pompiliu
    Lorenzen, Sylvie
    Bankstahl, Ulli S.
    Pauligk, Claudia
    Elshafei, Moustafa
    Amato, Giuseppe
    Reim, Daniel
    Bechstein, Wolf O.
    Koenigsrainer, Alfred
    Moenig, Stefan P.
    Rau, Beate
    Schwarzbach, Matthias
    Al-Batran, Salah-Eddin
    BMC CANCER, 2021, 21 (01)
  • [48] Patient compliance with prolonged erlotinib (E) treatment: experience from a phase I/II trial of perioperative concurrent chemoradiotherapy (CRT) and E followed by 2 years of maintenance E for stage III non-small cell lung cancer (NSCLC)
    Pennell, Nathan A.
    Videtic, Gregory M.
    Murthy, Sudish
    Mason, David
    Rice, Thomas W.
    Mazzone, Peter
    Samsa, Julia
    Rich, Tara
    Shapiro, Marc
    Mekhail, Tarek
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S860 - S860
  • [49] Preoperative chemoradiation and cetuximab for resectable, locally advanced esophageal cancer: Preliminary results of a prospective phase Ib/II trial.
    Brenner, Baruch
    Kundel, Yulia
    Purim, Ofer
    Medalia, Gal
    Olshinka, Liran
    Kashtan, Hanoch
    Menasherov, Nikolai
    Fenig, Eyal
    Sulkes, Aaron
    Idelevich, Efraim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as adjuvant treatment for stage II and III rectal cancer
    Jin, J.
    Li, Y. X.
    Wang, W. H.
    Liu, Y. P.
    Wang, K.
    Fang, H.
    Zhou, Z. X.
    Zhou, A. P.
    Wang, J. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S284 - S285
12345